Blocking a microRNA may prevent age-related conditions
Conditions like chronic inflammation, muscle loss and bone loss have an elevated microRNA, US researchers attempted to block this in aged mice.
List view / Grid view
Conditions like chronic inflammation, muscle loss and bone loss have an elevated microRNA, US researchers attempted to block this in aged mice.
Spreading cancer can halt natural pathway that should recruit killer T cells directly to where it has metastasised, US scientists report.
US researchers have developed a mouse model that holds promise in identifying the best organ donor and showing early signs of transplant rejection.
US scientists offer a new purpose for the blood pressure drug clonidine as a treatment to reduce the affects of PTSD.
US scientists have new insight into how heart cells enable unhealthy growth, and identify a new target to intervene against heart disease.
Scientists found in a murine model of acute respiratory distress syndrome (ARDS) that cannabidiol (CBD) helped the lungs recover from excessive inflammation caused by COVID-19.
A new study has found that in salt-sensitive hypertension, immune cells gather and release free radicals, damaging the kidneys.
A study has discovered the mechanism behind NSCLC resistance to chemotherapy, which could improve treatment strategies for the condition.
Scientists in the U.S. have reported findings about the mechanisms that contribute to the experience of weaker bones with age.
Scientists in the U.S. have reported that an experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can often continue months after a person has suffered the stroke.
A newly designed three-part molecule could be the one answer patients with a certain form of breast cancer are looking for...
Two distinctive handfuls of short molecules that regulate gene expression have been found in the eye fluid of patients with two distinct types of vision degenerating glaucoma.
A protein that typically helps keep cells organised and on task becomes a tumour suppressor in the face of liver cancer, scientists say.